Technology Licensing
The botanical new drugs developed by Der-Yen integrate scientific theory, academic research findings, animal pharmacological studies, and human clinical trials. After many years of effort, the company has become one of the few botanical new drug developers in Taiwan capable of effectively integrating:
- Identification of cellular target genes
- Plant screening and origin authentication
- Establishment of seedling cultivation and farming conditions, as well as contract farming guidance
- Extraction of active plant compounds and optimization of pharmaceutical applications
- Animal studies and human clinical trials
- Intellectual property application and acquisition
- Mass production technology and equipment design
- Quantification of active ingredients and quality control
The company possesses comprehensive experience in the development and mass production of botanical new drugs, providing strong capability for the internationalization of Taiwan’s botanical pharmaceuticals.
Therefore, we sincerely welcome collaborations with internationally renowned pharmaceutical companies to jointly explore the global medical market. If you are interested in learning more, please feel free to contact Der-Yen .